Monarch Capital Management Inc. boosted its holdings in Colgate-Palmolive Company (NYSE:CL) by 6.8% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,849 shares of the company’s stock after purchasing an additional 500 shares during the quarter. Monarch Capital Management Inc.’s holdings in Colgate-Palmolive were worth $582,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Chickasaw Capital Management LLC boosted its stake in Colgate-Palmolive by 218.3% in the 1st quarter. Chickasaw Capital Management LLC now owns 16,920 shares of the company’s stock worth $1,238,000 after purchasing an additional 11,605 shares during the period. Meritage Portfolio Management boosted its stake in Colgate-Palmolive by 0.3% in the 1st quarter. Meritage Portfolio Management now owns 95,879 shares of the company’s stock worth $7,017,000 after purchasing an additional 255 shares during the period. Alliancebernstein L.P. boosted its stake in Colgate-Palmolive by 4.2% in the 1st quarter. Alliancebernstein L.P. now owns 1,899,356 shares of the company’s stock worth $139,014,000 after purchasing an additional 77,414 shares during the period. Israel Discount Bank of New York bought a new position in Colgate-Palmolive in the 1st quarter worth approximately $1,349,000. Finally, ProShare Advisors LLC boosted its stake in Colgate-Palmolive by 9.9% in the 1st quarter. ProShare Advisors LLC now owns 879,652 shares of the company’s stock worth $64,382,000 after purchasing an additional 79,323 shares during the period. Institutional investors and hedge funds own 73.16% of the company’s stock.

Shares of Colgate-Palmolive Company (CL) opened at 72.18 on Friday. The stock has a market cap of $63.57 billion, a price-to-earnings ratio of 26.82 and a beta of 0.80. Colgate-Palmolive Company has a 12-month low of $63.43 and a 12-month high of $77.27. The company’s 50-day moving average price is $71.59 and its 200 day moving average price is $73.29.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.72. The company had revenue of $3.83 billion for the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The firm’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.70 earnings per share. On average, equities analysts predict that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This piece was published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.dailypolitical.com/2017/09/15/colgate-palmolive-company-cl-holdings-lifted-by-monarch-capital-management-inc.html.

In other Colgate-Palmolive news, Vice Chairman Franck J. Moison sold 35,000 shares of the business’s stock in a transaction on Monday, August 7th. The stock was sold at an average price of $71.52, for a total transaction of $2,503,200.00. Following the transaction, the insider now owns 201,411 shares of the company’s stock, valued at $14,404,914.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP John J. Huston sold 14,000 shares of the business’s stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $71.36, for a total value of $999,040.00. Following the transaction, the senior vice president now directly owns 88,598 shares in the company, valued at approximately $6,322,353.28. The disclosure for this sale can be found here. Insiders have sold 217,969 shares of company stock worth $15,693,933 in the last three months. 1.02% of the stock is currently owned by corporate insiders.

Several analysts have recently issued reports on the company. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price objective on the stock in a report on Tuesday, July 4th. Bank of America Corporation upped their price objective on Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a report on Wednesday, May 31st. Jefferies Group LLC reaffirmed a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a report on Thursday, August 24th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a report on Thursday, May 25th. Finally, Deutsche Bank AG reaffirmed a “hold” rating and set a $75.00 price objective on shares of Colgate-Palmolive in a report on Monday, July 24th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $75.82.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.